<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02931695</url>
  </required_header>
  <id_info>
    <org_study_id>2016-01</org_study_id>
    <nct_id>NCT02931695</nct_id>
  </id_info>
  <brief_title>Influence of Sex Hormones Variation During Third Trimester of Pregnancy and Post-partum on QT Interval Duration</brief_title>
  <acronym>QuTe</acronym>
  <official_title>Influence of Sex Hormones Variation During Third Trimester of Pregnancy and Post-partum on QT Interval Duration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre d'investigation clinique Paris-Est, Groupe Hospitalier Pitié-Salpetrière</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>INSERM 1166 ICAN UPMC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      QT interval prolongation, corrected for heart rate (QTc), either spontaneous or drug-induced,
      is associated with an increased risk of torsades de pointes and sudden death. Women are at
      higher risk of torsades de pointes, particularly during post-partum and the follicular phase.

      The aim of this study is to explore if QTc duration is prolonged during post-partum as
      compared to the 3rd trimester of pregnancy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sex steroid hormones are known to influence heart repolarization. Overall, estradiol is
      considered to promote QTc lengthening while progesterone and testosterone shorten QTc. New
      findings suggest more complex regulation of QTc by sex steroid hormones involving also
      follicle-stimulating hormone, which is associated to prolongation of QTc. Another important
      aim of this study is to study the influence of sex hormones on QTc duration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in QTcF duration (Corrected for heart rate according to Fridericia method) between third trimester of pregnancy and post-partum.</measure>
    <time_frame>third trimester of pregnancy and 3 to 6 months delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between circulating sex hormones levels (progesterone, estradiol, testosterone, FSH) and QTcF duration (univariate and multivariate analysis).</measure>
    <time_frame>third trimester of pregnancy and 3 to 6 months delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women during third trimester of pregnancy and in the first trimester of post partum
ECG
circulating sex hormones levels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>women in the first trimester of post partum</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women (same in first arm) in the first trimester of post partum
ECG
circulating sex hormones levels</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>evaluation of QT interval duration</intervention_name>
    <description>ECG to evaluation of QT interval duration</description>
    <arm_group_label>pregnant women</arm_group_label>
    <arm_group_label>women in the first trimester of post partum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>circulating sex hormones levels sample</intervention_name>
    <description>Association between circulating sex hormones levels (progesterone, estradiol, testosterone, FSH) and QTcF duration (univariate and multivariate analysis).</description>
    <arm_group_label>pregnant women</arm_group_label>
    <arm_group_label>women in the first trimester of post partum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt;18 yo) pregnant women in their third trimester

          -  Able to give her consent

        Exclusion Criteria:

          -  Concomitant intake of QTcF prolonging drugs

          -  Past medical history of cardiovascular or endocrino-metabolic conditions (except
             hypertension or diabetes)

          -  QRS &gt;120 msec on electrocardiogram
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joe-Elie SALEM, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'investigation Clinique - Paris est</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Justine POLLET</last_name>
    <phone>0144907033</phone>
    <email>justine.pollet@sfcardio.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre d'investigation Clinique - Paris est</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joe-Elie SALEM, MD-PHD</last_name>
      <phone>+33 01 42 17 85 31</phone>
      <email>joe-elie.salem@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Joe-Elie SALEM, MD-PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2016</study_first_submitted>
  <study_first_submitted_qc>October 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>post partum</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

